Nuclear phenotypical changes of human breast epithelial cells treated with carcinogens.
D015112:4-Nitroquinoline-1-oxide / Q000494:pharmacology*; D015127:9,10-Dimethyl-1,2-benzanthracene / Q000494:pharmacology*; D000328:Adult; D001940:Breast / Q000187:drug effects* / Q000648:ultrastructure; D002466:Cell Nucleolus / Q000648:ultrastructure; D002467:Cell Nucleus / Q000187:drug effects* / Q000648:ultrastructure; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced; D002478:Cells, Cultured; D002843:Chromatin / Q000648:ultrastructure; D005260:Female; D006801:Humans; D008770:Methylnitrosourea / Q000494:pharmacology*; D009600:Nitroquinolines / Q000494:pharmacology*; D010641:Phenotype
D002843:Chromatin; D009600:Nitroquinolines; D015112:4-Nitroquinoline-1-oxide; D015127:9,10-Dimethyl-1,2-benzanthracene; D008770:Methylnitrosourea